Avaliação laboratorial da toxidade da primaquina em dose duplicada e tempo reduzido no tratamento de malária por plasmodium vivax

Silva, Tatiany Oliveira de Alencar; Costa, Elenild de Goés; Pinto, Ana Yecê das Neves; Braga, Elizângela Sousa; Silva Filho, Manoel Gomes; Souza, José Maria de.
Rev. para. med ; 16(1): 9-13, jan.-abr. 2002. ilus, tab
Artigo em Português | LILACS | ID: lil-314729

Documentos relacionados

  1. Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
  2. Tafenoquine - A Radical Improvement?
  3. Higher-Dose Primaquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria.
  4. Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria.
  5. Primaquine for Plasmodium vivax malaria treatment.
  6. Primaquine for Plasmodium vivax malaria treatment - Authors' reply.
  7. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
  8. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
  9. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. Reply.
  10. Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response.